
Sign up to save your podcasts
Or


Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.
By Neuro-Oncology4.8
1212 ratings
Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.

30,687 Listeners

43,741 Listeners

7,707 Listeners

10,749 Listeners

318 Listeners

291 Listeners

3,349 Listeners

112,946 Listeners

56,549 Listeners

10,293 Listeners

9,202 Listeners

5,477 Listeners

16,095 Listeners

18,033 Listeners

10,254 Listeners